Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Establish a pilot program to provide benefits for menstrual hygiene products and diapers for individuals who receive temporary assistance for needy families, and to make an appropriation therefor.
Prohibit an insurer from declining or limiting life, disability, or long-term care insurance policies based solely on an individual's status as a living organ donor.